18755375

Source:http://linkedlifedata.com/resource/pubmed/id/18755375

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0014507, umls-concept:C0016884, umls-concept:C0033860, umls-concept:C0087111, umls-concept:C0152036, umls-concept:C1138555
pubmed:issue	5
pubmed:dateCreated	2008-8-29
pubmed:abstractText	Advances in the understanding and treatment of psoriasis in the past several years have been remarkable. New frontiers include better understanding the immunologic pathways that underlie the disease and the development of personalized strategies to maximize the benefit and minimize the risk for patients. Although a cure may not be imminent, there are some strategies under examination that may lead us closer to this goal.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8406412
pubmed:citationSubset	IM
pubmed:status	MEDLINE
pubmed:issn	0738-081X
pubmed:author	pubmed-author:KimballAlexa BAB, pubmed-author:KupperThomas STS
pubmed:issnType	Print
pubmed:volume	26
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	554-61
pubmed:meshHeading	pubmed-meshheading:18755375-Humans, pubmed-meshheading:18755375-Immunotherapy, pubmed-meshheading:18755375-Psoriasis, pubmed-meshheading:18755375-T-Lymphocytes
pubmed:articleTitle	Future perspectives/quo vadis psoriasis treatment? Immunology, pharmacogenomics, and epidemiology.
pubmed:affiliation	Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02114, USA. harvardskinstudies@partners.org
pubmed:publicationType	Journal Article, Review